SCHEMBL5841267

SCHEMBL5841267

CC(=O)Nc1ccc(S(=O)(=O)Cl)cc1[N+](=O)[O-]

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.60
POLB P06746 1/20 0.60
MAPT P10636 5/20 0.59
NPSR1 Q6W5P4 2/20 0.59
ALDH3A1 P30838 2/20 0.59
ALDH1A1 P00352 7/20 0.54
KMT2A Q03164 3/20 0.54
LMNA P02545 3/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
MEN1 O00255 1/20 0.54
HTT P42858 2/20 0.54
TDP1 Q9NUW8 1/20 0.53
GAA P10253 2/20 0.50
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA9 Q16790 2/20 0.48
ABCC9 O60706 1/20 0.46
ABCC8 Q09428 1/20 0.46
KCNJ11 Q14654 1/20 0.46
KCNJ8 Q15842 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18653823 0.88 MAPT (0.62) PKMPOLBMAPTNPSR1ALDH3A1
SCHEMBL7591545 0.87 MAPT (0.61) PKMPOLBMAPTNPSR1ALDH3A1
SCHEMBL11629310 0.87 ALDH3A1 (0.76) PKMPOLBMAPTNPSR1ALDH3A1
SCHEMBL11686855 0.85 CA1 (0.64) PKMPOLBMAPTNPSR1ALDH3A1
SCHEMBL5786327 0.82 KMT2A (0.78) PKMPOLBMAPTNPSR1ALDH3A1
SCHEMBL22659052 0.81 HCAR3 (0.54) PKMPOLBMAPTALDH3A1ALDH1A1
SCHEMBL5951705 0.81 KMT2A (0.53) PKMPOLBMAPTALDH1A1KMT2A
SCHEMBL10712446 0.80 MAPT (0.64) PKMPOLBMAPTNPSR1ALDH1A1
SCHEMBL7163402 0.80 ALDH1A1 (0.47) PKMPOLBMAPTNPSR1ALDH3A1
SCHEMBL2282371 0.80 MAPT (0.68) PKMPOLBMAPTNPSR1ALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10026553-B2 Organic compound, crystal dielectric layer and capacitor CAPACITOR SCIENCES INCORPORATED (US) 2018-07-17 US disclosed
US-10026553-B2 Organic compound, crystal dielectric layer and capacitor CAPACITOR SCIENCES INCORPORATED (US) 2018-07-17 US disclosed
WO-2017070249-A1 ORGANIC COMPOUND, CRYSTAL DIELECTRIC LAYER AND CAPACITOR BACKGROUND CAPACITOR SCIENCES INCORPORATED (US) 2017-04-27 WO disclosed
US-20170117097-A1 ORGANIC COMPOUND, CRYSTAL DIELECTRIC LAYER AND CAPACITOR CAPACITOR SCIENCES INCORPORATED 2017-04-27 US disclosed
US-20170117097-A1 ORGANIC COMPOUND, CRYSTAL DIELECTRIC LAYER AND CAPACITOR CAPACITOR SCIENCES INCORPORATED 2017-04-27 US disclosed
US-7138530-B2 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2006-11-21 US disclosed
US-7109354-B2 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2006-09-19 US disclosed
EP-1549632-A4 NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS DIMENSIONAL PHARM INC (US) 2005-11-09 EP disclosed
US-20050234081-A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions SUBASINGHE NALIN 2005-10-20 US disclosed
EP-1549632-A1 NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2005-07-06 EP disclosed
US-20040009995-A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions 3-DIMENSIONAL PHARMACEUTICALS, INC. 2004-01-15 US disclosed
WO-2003099805-A1 NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2003-12-04 WO disclosed
US-5359132-A Process for the preparation of sodium salts of aromatic sulphinic acids containing nitro groups BAYER AKTIENGESELLSCHAFT (DE) 1994-10-25 US disclosed
US-4567252-A Water-insoluble naphthol monoazo dyestuff CASSELLA AKTIENGESELLSCHAFT (DE) 1986-01-28 US disclosed
EP-0096789-A1 Water-insoluble monoazo dyestuffs, their preparation and their use CASSELLA Aktiengesellschaft (DE) 1983-12-28 EP disclosed
US-4005199-A Substituted benzenesulfonamides as anthelmintics MERCK & CO., INC. (US) 1977-01-25 US disclosed
US-3987199-A PARASITICIDES MERCK & CO., INC. (US) 1976-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234081-A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions C5, C9, C1R PKM 3263/4885POLB 4582/4885MAPT 3296/4885
US-20170117097-A1 ORGANIC COMPOUND, CRYSTAL DIELECTRIC LAYER AND CAPACITOR PIEZO1, FOXO1, FOXM1 PKM 1969/4885POLB 4101/4885MAPT 4560/4885
US-20040009995-A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions C5, C9, C1R PKM 4070/4885POLB 4433/4885MAPT 2762/4885
US-10026553-B2 Organic compound, crystal dielectric layer and capacitor PIEZO1, FOXO1, FOXM1 PKM 1969/4885POLB 4101/4885MAPT 4560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.